Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
OOF by DongKoo Bio & Pharma for Hypertension: Likelihood of Approval
OOF is under clinical development by DongKoo Bio & Pharma and currently in Phase I for Hypertension. According to GlobalData,...
Data Insights
OOF by DongKoo Bio & Pharma for Idiopathic (Essential) Hypertension: Likelihood of Approval
OOF is under clinical development by DongKoo Bio & Pharma and currently in Phase I for Idiopathic (Essential) Hypertension. According...